The Paf oncogene is essential for hematopoietic stem cell function and development

Yacine M. Amrani, Jonathan Gill, Armine Matevossian, Eric S. Alonzo, Chingwen Yang, Jae Hung Shieh, Malcolm A. Moore, Christopher Y. Park, Derek B. Sant'Angelo, Lisa K. Denzin

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Hematopoietic stem cells (HSCs) self-renew to maintain the lifelong production of all blood populations. Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expressed in cycling bone marrow HSCs and plays a critical role in hematopoiesis. Mice lacking Paf exhibited reduced bone marrow cellularity; reduced numbers of HSCs and committed progenitors; and leukopenia. These phenotypes are caused by a cellintrinsic blockage in the development of long-term (LT)-HSCs into multipotent progenitors and preferential loss of lymphoid progenitors caused by markedly increased p53-mediated apoptosis. In addition, LT-HSCs from Paf-/- mice had increased levels of reactive oxygen species (ROS), failed to maintain quiescence, and were unable to support LT hematopoiesis. The loss of lymphoid progenitors was likely due the increased levels of ROS in LT-HSCs caused by treatment of Paf-/- mice with the anti-oxidant N-acetylcysteine restored lymphoid progenitor numbers to that of Paf+/+ mice. Collectively, our studies identify Paf as a novel and essential regulator of early hematopoiesis. 2011 Amrani et al.

Original languageEnglish (US)
Pages (from-to)1757-1765
Number of pages9
JournalJournal of Experimental Medicine
Volume208
Issue number9
DOIs
StatePublished - Aug 29 2011
Externally publishedYes

Fingerprint

Hematopoietic Stem Cells
Oncogenes
Hematopoiesis
Reactive Oxygen Species
Bone Marrow
Leukopenia
Proliferating Cell Nuclear Antigen
Acetylcysteine
Oxidants
Apoptosis
Phenotype
Population

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Medicine(all)

Cite this

Amrani, Y. M., Gill, J., Matevossian, A., Alonzo, E. S., Yang, C., Shieh, J. H., ... Denzin, L. K. (2011). The Paf oncogene is essential for hematopoietic stem cell function and development. Journal of Experimental Medicine, 208(9), 1757-1765. https://doi.org/10.1084/jem.20102170

The Paf oncogene is essential for hematopoietic stem cell function and development. / Amrani, Yacine M.; Gill, Jonathan; Matevossian, Armine; Alonzo, Eric S.; Yang, Chingwen; Shieh, Jae Hung; Moore, Malcolm A.; Park, Christopher Y.; Sant'Angelo, Derek B.; Denzin, Lisa K.

In: Journal of Experimental Medicine, Vol. 208, No. 9, 29.08.2011, p. 1757-1765.

Research output: Contribution to journalArticle

Amrani, YM, Gill, J, Matevossian, A, Alonzo, ES, Yang, C, Shieh, JH, Moore, MA, Park, CY, Sant'Angelo, DB & Denzin, LK 2011, 'The Paf oncogene is essential for hematopoietic stem cell function and development', Journal of Experimental Medicine, vol. 208, no. 9, pp. 1757-1765. https://doi.org/10.1084/jem.20102170
Amrani YM, Gill J, Matevossian A, Alonzo ES, Yang C, Shieh JH et al. The Paf oncogene is essential for hematopoietic stem cell function and development. Journal of Experimental Medicine. 2011 Aug 29;208(9):1757-1765. https://doi.org/10.1084/jem.20102170
Amrani, Yacine M. ; Gill, Jonathan ; Matevossian, Armine ; Alonzo, Eric S. ; Yang, Chingwen ; Shieh, Jae Hung ; Moore, Malcolm A. ; Park, Christopher Y. ; Sant'Angelo, Derek B. ; Denzin, Lisa K. / The Paf oncogene is essential for hematopoietic stem cell function and development. In: Journal of Experimental Medicine. 2011 ; Vol. 208, No. 9. pp. 1757-1765.
@article{920eca98ed88494eb41a28c8dba3290f,
title = "The Paf oncogene is essential for hematopoietic stem cell function and development",
abstract = "Hematopoietic stem cells (HSCs) self-renew to maintain the lifelong production of all blood populations. Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expressed in cycling bone marrow HSCs and plays a critical role in hematopoiesis. Mice lacking Paf exhibited reduced bone marrow cellularity; reduced numbers of HSCs and committed progenitors; and leukopenia. These phenotypes are caused by a cellintrinsic blockage in the development of long-term (LT)-HSCs into multipotent progenitors and preferential loss of lymphoid progenitors caused by markedly increased p53-mediated apoptosis. In addition, LT-HSCs from Paf-/- mice had increased levels of reactive oxygen species (ROS), failed to maintain quiescence, and were unable to support LT hematopoiesis. The loss of lymphoid progenitors was likely due the increased levels of ROS in LT-HSCs caused by treatment of Paf-/- mice with the anti-oxidant N-acetylcysteine restored lymphoid progenitor numbers to that of Paf+/+ mice. Collectively, our studies identify Paf as a novel and essential regulator of early hematopoiesis. 2011 Amrani et al.",
author = "Amrani, {Yacine M.} and Jonathan Gill and Armine Matevossian and Alonzo, {Eric S.} and Chingwen Yang and Shieh, {Jae Hung} and Moore, {Malcolm A.} and Park, {Christopher Y.} and Sant'Angelo, {Derek B.} and Denzin, {Lisa K.}",
year = "2011",
month = "8",
day = "29",
doi = "10.1084/jem.20102170",
language = "English (US)",
volume = "208",
pages = "1757--1765",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "9",

}

TY - JOUR

T1 - The Paf oncogene is essential for hematopoietic stem cell function and development

AU - Amrani, Yacine M.

AU - Gill, Jonathan

AU - Matevossian, Armine

AU - Alonzo, Eric S.

AU - Yang, Chingwen

AU - Shieh, Jae Hung

AU - Moore, Malcolm A.

AU - Park, Christopher Y.

AU - Sant'Angelo, Derek B.

AU - Denzin, Lisa K.

PY - 2011/8/29

Y1 - 2011/8/29

N2 - Hematopoietic stem cells (HSCs) self-renew to maintain the lifelong production of all blood populations. Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expressed in cycling bone marrow HSCs and plays a critical role in hematopoiesis. Mice lacking Paf exhibited reduced bone marrow cellularity; reduced numbers of HSCs and committed progenitors; and leukopenia. These phenotypes are caused by a cellintrinsic blockage in the development of long-term (LT)-HSCs into multipotent progenitors and preferential loss of lymphoid progenitors caused by markedly increased p53-mediated apoptosis. In addition, LT-HSCs from Paf-/- mice had increased levels of reactive oxygen species (ROS), failed to maintain quiescence, and were unable to support LT hematopoiesis. The loss of lymphoid progenitors was likely due the increased levels of ROS in LT-HSCs caused by treatment of Paf-/- mice with the anti-oxidant N-acetylcysteine restored lymphoid progenitor numbers to that of Paf+/+ mice. Collectively, our studies identify Paf as a novel and essential regulator of early hematopoiesis. 2011 Amrani et al.

AB - Hematopoietic stem cells (HSCs) self-renew to maintain the lifelong production of all blood populations. Here, we show that the proliferating cell nuclear antigen-associated factor (Paf) is highly expressed in cycling bone marrow HSCs and plays a critical role in hematopoiesis. Mice lacking Paf exhibited reduced bone marrow cellularity; reduced numbers of HSCs and committed progenitors; and leukopenia. These phenotypes are caused by a cellintrinsic blockage in the development of long-term (LT)-HSCs into multipotent progenitors and preferential loss of lymphoid progenitors caused by markedly increased p53-mediated apoptosis. In addition, LT-HSCs from Paf-/- mice had increased levels of reactive oxygen species (ROS), failed to maintain quiescence, and were unable to support LT hematopoiesis. The loss of lymphoid progenitors was likely due the increased levels of ROS in LT-HSCs caused by treatment of Paf-/- mice with the anti-oxidant N-acetylcysteine restored lymphoid progenitor numbers to that of Paf+/+ mice. Collectively, our studies identify Paf as a novel and essential regulator of early hematopoiesis. 2011 Amrani et al.

UR - http://www.scopus.com/inward/record.url?scp=80054834594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80054834594&partnerID=8YFLogxK

U2 - 10.1084/jem.20102170

DO - 10.1084/jem.20102170

M3 - Article

C2 - 21844206

AN - SCOPUS:80054834594

VL - 208

SP - 1757

EP - 1765

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 9

ER -